TiKo

(+370) 625 55118

  • Home
  • Team
  • Peptides
  • Bacterial cellulose
  • LB
  • SCF
  • HS
  • For investors
  • More
    • Home
    • Team
    • Peptides
    • Bacterial cellulose
    • LB
    • SCF
    • HS
    • For investors

(+370) 625 55118

TiKo
  • Home
  • Team
  • Peptides
  • Bacterial cellulose
  • LB
  • SCF
  • HS
  • For investors

The Problem

Today, one of the most promising approaches in regenerative medicine for treating tissue defects is tissue engineering. This method involves using matrices (scaffolds) to create a framework for damaged organs or organ components, which are then populated with biologically active substances.

The goal of the proposed project is to develop an innovative product for tissue regeneration that utilises a bacterial cellulose scaffold enriched with autologous extracellular growth factors. This combination aims to enhance the regenerative process, promoting effective healing and tissue restoration.

Consist of

Our company has deposited bacterial strains responsible for the production of bacterial cellulose. The Medusomyces gisevii culture was deposited and assigned the registration number Sa-28. Five strains of microorganisms were isolated from this culture, including one bacterial culture and four yeast. All five cultures were deposited and assigned registration numbers:

  • Yeast culture Brettanomyces bruxellensis ink-01-1 (Y-5060);
  • Yeast culture Brettanomyces bruxellensis ink-01-2 (Y-5061);
  • Yeast culture Brettanomyces bruxellensis ink-01-3 (Y-5062);
  • Yeast culture Pichia manshurica ink-01-4 (Y-5063);
  • Bacterial culture Komagataeibacter xylinus ink-01-5 (B-14280).

Pure and clear

The potential for utilizing bacterial cellulose (BC) and scaffolds derived from it in pharmaceuticals and medicine highlights the importance of purity and the absence of bacterial endotoxins as critical characteristics. Endotoxins are components found within certain bacteria that are released only when the bacterial cells are lysed. Ensuring that BC and its scaffolds are free from these contaminants is essential for their safety and efficacy in medical applications.

The moisture capacity

All produced scaffold samples demonstrate high efficiency. The scaffold made from pure bacterial cellulose (BC) (No. 1) has a moisture capacity of 2714%. Notably, the inclusion of additional components further enhances this moisture capacity. Analysis shows that the addition of mixed peptides, irrespective of whether a formative agent is present, results in a moisture capacity exceeding 5000%.

Furthermore, all scaffold samples exhibit a high porosity index, ranging from 95% to 98.7%. These exceptional moisture retention and porosity indices indicate the superior quality of all the obtained scaffold samples.

Biocompatibility

When studying bacterial cellulose on a chicken embryo model, the high level of biocompatibility of the selected scaffold variants was confirmed.

Patient Resources

We believe that knowledge is power when it comes to your health. That's why we provide a variety of patient resources, including educational materials, support groups, and access to our patient portal.

Our Wellness in Photos: A Picture is Worth a Thousand Words

Angiogenesis and harmlessness test of bacterial cellulose

Copyright © 2024 TiKo - All Rights Reserved.

UAB INKOM EUROPE

Registration code: 305191516 

VAT: LT100013554511 

Powered by

  • Home
  • Team
  • Peptides
  • Bacterial cellulose
  • LB
  • SCF
  • HS

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept